Skip to content

Effect of vaginal preparation with chlorhexidine before cesarean section on the rate of endometritis and post operative wound infection

Evaluation of vaginal prep with chlorhexidine in comparison with normal saline before cesarean section on endometritis and post operative wound infection in the pregnant women undergoing cesarean section

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20210415050982N1
Enrollment
320
Registered
2021-05-26
Start date
2021-04-29
Completion date
Unknown
Last updated
2021-06-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

endometritis and post operative wound infection in the pregnant women undergoing cesarean section. Endometritis following delivery

Interventions

Intervention 1: Intervention group: In addition to abdominal rinsing with betadine and antibiotic injections, rinsing with 0.05% chlorhexidine-impregnated sterile gas will be performed around and insi

Sponsors

Qazvin University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: All pregnant women with cesarean section indication

Exclusion criteria

Exclusion criteria: Diabetes Chorioamnionitis Severe anemia Meconium excretion Multiple pregnancy (Twin and more) Long-term rupture of bladder (more than 18 hours)

Design outcomes

Primary

MeasureTime frame
Occurrence of endometritis. Timepoint: Patients will be evaluated for signs of endometritis (fever 38.8 ° C or higher 24 hours after surgery) during the first 10 days after cesarean section. Method of measurement: check list.;Abdominal incision site infection. Timepoint: During the first 10 days after cesarean section, patients will be examined for infection of the incision site (redness or opening of the wound edges with the removal of purulent discharge). Method of measurement: check list.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNasibeh Parsaei athar

Qazvin University of Medical Sciences

Ngo1366@yahoo.com+98 912 246 7846

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026